title: Heparin-induced thrombocytopenia in the setting of perioperative bridging for podiatric surgery: a case report.
abstract: Heparin is an anticoagulant commonly used to treat and prevent deep venous thrombosis. Heparin-induced thrombocytopenia and possible thrombosis are serious complications associated with its use. This can occasionally complicate treatment of patients undergoing podiatric surgery. Heparin-induced thrombocytopenia is often not immediately recognized and is underreported in podiatric medicine literature. The goal of this case report is to highlight the multiple risk factors associated with the development of heparin-induced thrombocytopenia and to aid with early recognition, understanding of pathogenesis, and treatment options.
authors: Department of Podiatry, Carl T. Hayden VA Medical Center, Phoenix, AZ 85012, USA. Robert.Frykberg@med.va.gov
authors: Robert G
authors: RG
authors: Frykberg
authors: Scott
authors: S
authors: Gordon
authors: Edward
authors: E
authors: Tierney
authors: Arthur
authors: A
authors: Tallis
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects*; D005528:Foot / Q000601:surgery*; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D059035:Perioperative Period; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000150:complications / Q000175:diagnosis; D013927:Thrombosis / Q000517:prevention & control*
chemical_list: D000925:Anticoagulants; D006493:Heparin